Orphan Drugs Market Growth Opportunities, Sales, Revenue global Orphan Drugs market | Page 5

7.9.2 Orphan Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Celgene Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Biogen IDEC
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Orphan Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Biogen IDEC Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin
(2012-2017)
7.10.4 Main Business/Business Overview
7.11 Pharmacyclics
7.12 Vertex
7.13 Onyx
7.14 AstraZeneca
7.15 Baxter
8 Orphan Drugs Manufacturing Cost Analysis
8.1 Orphan Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Orphan Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Orphan Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk